Revolution Medicines (RVMD) total liabilities

Total liabilities · fiscal 2025
$723.21M

Revolution Medicines (RVMD) had total liabilities of $723.21M at the end of fiscal 2025 (December 31, 2025). That is 146.7% higher than the $293.10M of fiscal 2024. Figures as of 18 Nov 2026, 20:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$723.21M
Change on fiscal 2024
+146.7%
Growth, 5 years
+50.8% a year
Highest on record
$723.21Mfiscal 2025
Lowest on record
$67.99Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revolution Medicines total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 50.8% a year. Across the 7 fiscal years on record (2019–2025), the highest was $723.21M in fiscal 2025 and the lowest $67.99M in fiscal 2019.

History · 7 fiscal years

Total liabilities by fiscal year

Revolution Medicines total liabilities, year by year

Revolution Medicines (RVMD) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$723.21M 146.7% up
2024$293.10M 24.5% up
2023$235.51M 85.8% up
2022$126.74M 6.4% down
2021$135.42M 46.0% up
2020$92.73M 36.4% up
2019$67.99M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Revolution Medicines and comparable companies
CompanyTotal liabilitiesFiscal year
BeOne Medicines ONC$3.83B2025
Waters WAT$2.52B2025
Natera NTRA$685.93M2025
IQVIA Holdings IQV$23.31B2025
Revolution Medicines RVMD$723.21M2025
Royalty Pharma RPRX$9.91B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines total liabilities: questions and answers

How large are Revolution Medicines's total liabilities?

Revolution Medicines (RVMD) had total liabilities of $723.21M at the end of fiscal 2025 (December 31, 2025). That is 146.7% higher than the $293.10M of fiscal 2024.

What is the growth rate of Revolution Medicines's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 50.8% a year.

What are the highest and lowest total liabilities figures on record for Revolution Medicines?

Across the 7 fiscal years on record (2019–2025), the highest was $723.21M in fiscal 2025 and the lowest $67.99M in fiscal 2019.

How is Revolution Medicines's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Revolution Medicines it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/RVMD/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.